Whitepaper: Opportunities in preclinical development
Posted: 11 July 2018 | IDBS | No comments yet
This whitepaper explains how you can find ways to optimise the holistic preclinical development process…
When it comes to informatics and data management, each preclinical domain is characterised by specific requirements due to their diverse scientific needs.
This whitepaper explains how you can find ways to optimise the holistic preclinical development process by examining the needs of pharmacology, drug metabolism, pharmacokinetics, bioanalysis, formulations, and safety/toxicology.
This whitepaper is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
- An integrated vaccination approach to neurodegeneration
- ebook: High-Throughput Data Management in process development
- Whitepaper: Buying a digital informatics system for your R&D?
- Making cell culture models more physiologically relevant
- ebook: Why you need to digitally transform your R&D organisation
Related topics
Assays, Drug Discovery, Drug Discovery Processes, Genomics, Informatics, Screening, Sequencing, Stem Cells, Target molecule, Target Validation, toxicology, Translational Science
Related organisations
IDBS
